Literature DB >> 30842876

Prostate-specific antigen glycoprofiling as diagnostic and prognostic biomarker of prostate cancer.

Jan Tkac1,2, Veronika Gajdosova1, Stefania Hroncekova1, Tomas Bertok1,2, Michal Hires1, Eduard Jane1, Lenka Lorencova1,2, Peter Kasak3.   

Abstract

The initial part of this review details the controversy behind the use of a serological level of prostate-specific antigen (PSA) for the diagnostics of prostate cancer (PCa). Novel biomarkers are in demand for PCa diagnostics, outperforming traditional PSA tests. The review provides a detailed and comprehensive summary that PSA glycoprofiling can effectively solve this problem, thereby considerably reducing the number of unnecessary biopsies. In addition, PSA glycoprofiling can serve as a prognostic PCa biomarker to identify PCa patients with an aggressive form of PCa, avoiding unnecessary further treatments which are significantly life altering (incontinence or impotence).

Entities:  

Keywords:  biomarkers; diagnostics; glycans; lectins; prostate cancer; prostate-specific antigen

Year:  2019        PMID： 30842876      PMCID： PMC6388024          DOI： 10.1098/rsfs.2018.0077

Source DB:  PubMed          Journal:  Interface Focus        ISSN： 2042-8898            Impact factor:   3.906


  65 in total

Review 1.  Glycosylation of prostate specific antigen and its potential diagnostic applications.

Authors:  Tijl Vermassen; Marijn M Speeckaert; Nicolaas Lumen; Sylvie Rottey; Joris R Delanghe
Journal:  Clin Chim Acta       Date:  2012-06-18       Impact factor: 3.786

2.  Crystal structure of human prostate-specific antigen in a sandwich antibody complex.

Authors:  Enrico A Stura; Bruno H Muller; Marc Bossus; Sandrine Michel; Colette Jolivet-Reynaud; Frédéric Ducancel
Journal:  J Mol Biol       Date:  2011-10-20       Impact factor: 5.469

3.  A sensitive assay to measure biomarker glycosylation demonstrates increased fucosylation of prostate specific antigen (PSA) in patients with prostate cancer compared with benign prostatic hyperplasia.

Authors:  Miriam V Dwek; Andrew Jenks; Anthony J C Leathem
Journal:  Clin Chim Acta       Date:  2010-08-12       Impact factor: 3.786

4.  Simultaneous analysis of glycosylated and sialylated prostate-specific antigen revealing differential distribution of glycosylated prostate-specific antigen isoforms in prostate cancer tissues.

Authors:  Yan Li; Yuan Tian; Taha Rezai; Amol Prakash; Mary F Lopez; Daniel W Chan; Hui Zhang
Journal:  Anal Chem       Date:  2010-12-08       Impact factor: 6.986

5.  Detection and verification of glycosylation patterns of glycoproteins from clinical specimens using lectin microarrays and lectin-based immunosorbent assays.

Authors:  Yan Li; Sheng-Ce Tao; G Steven Bova; Alvin Y Liu; Daniel W Chan; Heng Zhu; Hui Zhang
Journal:  Anal Chem       Date:  2011-10-26       Impact factor: 6.986

6.  alpha1,2-Fucosylated and beta-N-acetylgalactosaminylated prostate-specific antigen as an efficient marker of prostatic cancer.

Authors:  Keiko Fukushima; Takefumi Satoh; Shiro Baba; Katsuko Yamashita
Journal:  Glycobiology       Date:  2009-12-11       Impact factor: 4.313

7.  Lectin and serum-PSA interaction as a screening test for prostate cancer.

Authors:  Pranab S Basu; Ramdhan Majhi; Sandip K Batabyal
Journal:  Clin Biochem       Date:  2003-07       Impact factor: 3.281

8.  Glycoproteomics for prostate cancer detection: changes in serum PSA glycosylation patterns.

Authors:  Danni L Meany; Zhen Zhang; Lori J Sokoll; Hui Zhang; Daniel W Chan
Journal:  J Proteome Res       Date:  2009-02       Impact factor: 4.466

9.  Glycomic characterization of prostate-specific antigen and prostatic acid phosphatase in prostate cancer and benign disease seminal plasma fluids.

Authors:  Krista Y White; Lucy Rodemich; Julius O Nyalwidhe; Mary Ann Comunale; Mary Ann Clements; Raymond S Lance; Paul F Schellhammer; Anand S Mehta; O John Semmes; Richard R Drake
Journal:  J Proteome Res       Date:  2009-02       Impact factor: 4.466

10.  Multiplexed analysis of glycan variation on native proteins captured by antibody microarrays.

Authors:  Songming Chen; Tom LaRoche; Darren Hamelinck; Derek Bergsma; Dean Brenner; Diane Simeone; Randall E Brand; Brian B Haab
Journal:  Nat Methods       Date:  2007-04-08       Impact factor: 28.547
View more
  9 in total

1.  Advanced impedimetric biosensor configuration and assay protocol for glycoprofiling of a prostate oncomarker using Au nanoshells with a magnetic core.

Authors:  Tomas Bertok; Lenka Lorencova; Stefania Hroncekova; Veronika Gajdosova; Eduard Jane; Michal Hires; Peter Kasak; Ondrej Kaman; Roman Sokol; Vladimir Bella; Anita Andicsova Eckstein; Jaroslav Mosnacek; Alica Vikartovska; Jan Tkac
Journal:  Biosens Bioelectron       Date:  2019-02-01       Impact factor: 12.545

2.  Ultrasensitive Ti3C2TX MXene/Chitosan Nanocomposite-Based Amperometric Biosensor for Detection of Potential Prostate Cancer Marker in Urine Samples.

Authors:  Stefania Hroncekova; Tomas Bertok; Michal Hires; Eduard Jane; Lenka Lorencova; Alica Vikartovska; Aisha Tanvir; Peter Kasak; Jan Tkac
Journal:  Processes (Basel)       Date:  2020-05-13       Impact factor: 2.847

3.  A Graphene-Based Glycan Biosensor for Electrochemical Label-Free Detection of a Tumor-Associated Antibody.

Authors:  Filip Kveton; Anna Blsakova; Lenka Lorencova; Monika Jerigova; Dusan Velic; Ola Blixt; Bo Jansson; Peter Kasak; Jan Tkac
Journal:  Sensors (Basel)       Date:  2019-12-09       Impact factor: 3.576

4.  Highly Selective Optical Sensor Eu (TTA)3 Phen Embedded in Poly Methylmethacrylate for Assessment of Total Prostate Specific Antigen Tumor Marker in Male Serum Suffering Prostate Diseases.

Authors:  Mohannad Garoub; A H Hefny; W E Omer; Mostafa M Elsaady; Mohamed M Abo-Aly; Ali A Sayqal; Ahmed Alharbi; Ahmed Hameed; Hussain Alessa; A O Youssef; Ekram H Mohamed; Ayman A Gouda; R El Sheikh; M N Abou-Omar; Maged A El-Kemary; M S Attia
Journal:  Front Chem       Date:  2020-11-19       Impact factor: 5.221

Review 5.  Gold Nanoparticles Based Optical Biosensors for Cancer Biomarker Proteins: A Review of the Current Practices.

Authors:  Jinghua Tai; Shuang Fan; Siqi Ding; Lishen Ren
Journal:  Front Bioeng Biotechnol       Date:  2022-04-26

6.  Aptamers targeting protein-specific glycosylation in tumor biomarkers: general selection, characterization and structural modeling.

Authors:  Ana Díaz-Fernández; Rebeca Miranda-Castro; Natalia Díaz; Dimas Suárez; Noemí de-Los-Santos-Álvarez; M Jesús Lobo-Castañón
Journal:  Chem Sci       Date:  2020-07-21       Impact factor: 9.825

Review 7.  Esophageal, gastric and colorectal cancers: Looking beyond classical serological biomarkers towards glycoproteomics-assisted precision oncology.

Authors:  Elisabete Fernandes; Janine Sores; Sofia Cotton; Andreia Peixoto; Dylan Ferreira; Rui Freitas; Celso A Reis; Lúcio Lara Santos; José Alexandre Ferreira
Journal:  Theranostics       Date:  2020-03-31       Impact factor: 11.556

Review 8.  Electrochemical Nanobiosensors for Detection of Breast Cancer Biomarkers.

Authors:  Veronika Gajdosova; Lenka Lorencova; Peter Kasak; Jan Tkac
Journal:  Sensors (Basel)       Date:  2020-07-20       Impact factor: 3.576

9.  Alterations in protein expression and site-specific N-glycosylation of prostate cancer tissues.

Authors:  Simon Sugár; Gábor Tóth; Fanni Bugyi; Károly Vékey; Katalin Karászi; László Drahos; Lilla Turiák
Journal:  Sci Rep       Date:  2021-08-05       Impact factor: 4.379
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.